Metabolic Solutions Development Company Awarded Funding by The Michael J. Fox Foundation

KALAMAZOO, Mich., Feb. 7, 2013 – Metabolic Solutions Development Company, LLC (MSDC) announced today that it has received an award from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to conduct preclinical research on a first-in-class mTOT Modulator, MSDC-0160, as a potential treatment for levodopa induced dyskinesia (LID). The study will be undertaken in collaboration with Patrik Brundin, MD, PhD, of Van Andel Institute (VAI)…

PDF: Metabolic Solutions Development Company Awarded Funding by The Michael J. Fox Foundation